In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 29th, 2005 | 18 | Yes |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.15 | 7.21 | -8.67 | 1 | 3 | 0 | 42 | 239.253 | 2 | ↓ |
Mid Mid (pH 6-8) | 2.15 | 7.66 | -43.88 | 2 | 3 | 1 | 43 | 240.261 | 2 | ↓ |
Lo Low (pH 4.5-6) | 2.15 | 7.51 | -36.99 | 2 | 3 | 1 | 43 | 240.261 | 2 | ↓ |
Lo Low (pH 4.5-6) | 2.15 | 7.96 | -96.35 | 3 | 3 | 2 | 44 | 241.269 | 2 | ↓ |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK09-1-E | C-Jun N-terminal Kinase 2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 195 | 0.52 | Binding ≤ 10μM |
MK11-1-E | MAP Kinase P38 Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.52 | Binding ≤ 10μM |
MK12-1-E | MAP Kinase P38 Gamma (cluster #1 Of 2), Eukaryotic | Eukaryotes | 210 | 0.52 | Binding ≤ 10μM |
MK13-1-E | MAP Kinase P38 Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 210 | 0.52 | Binding ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 79 | 0.55 | Binding ≤ 10μM |
RAF1-1-E | Serine/threonine-protein Kinase RAF (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.46 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 195 | 0.52 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 170 | 0.53 | Binding ≤ 1μM |
MK14_MOUSE | P47811 | MAP Kinase P38 Alpha, Mouse | 1000 | 0.47 | Binding ≤ 1μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 170 | 0.53 | Binding ≤ 1μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 170 | 0.53 | Binding ≤ 1μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 170 | 0.53 | Binding ≤ 1μM |
MK09_HUMAN | P45984 | C-Jun N-terminal Kinase 2, Human | 195 | 0.52 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 170 | 0.53 | Binding ≤ 10μM |
MK14_MOUSE | P47811 | MAP Kinase P38 Alpha, Mouse | 1000 | 0.47 | Binding ≤ 10μM |
MK11_HUMAN | Q15759 | MAP Kinase P38 Beta, Human | 170 | 0.53 | Binding ≤ 10μM |
MK13_HUMAN | O15264 | MAP Kinase P38 Delta, Human | 170 | 0.53 | Binding ≤ 10μM |
MK12_HUMAN | P53778 | MAP Kinase P38 Gamma, Human | 170 | 0.53 | Binding ≤ 10μM |
RAF1_HUMAN | P04049 | Serine/threonine-protein Kinase RAF, Human | 1300 | 0.46 | Binding ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
CDO in myogenesis | |
CREB phosphorylation through the activation of Ras | |
DSCAM interactions | |
ERK/MAPK targets | |
FCERI mediated MAPK activation | |
GP1b-IX-V activation signalling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
KSRP destabilizes mRNA | |
MEK activation | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p38MAPK events | |
Platelet sensitization by LDL | |
RAF activation | |
RAF phosphorylates MEK | |
Rap1 signalling | |
Stimuli-sensing channels | |
VEGFA-VEGFR2 Pathway |
No pre-computed analogs available. Try a structural similarity search.